Prelude Capital Management’s BioAtla BCAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-30,410
| Closed | -$53.5K | – | 1097 |
|
|
2024
Q3 | $53.5K | Buy |
+30,410
| New | +$53.5K | ﹤0.01% | 1108 |
|
|
2023
Q4 | – | Sell |
-11,083
| Closed | -$18.8K | – | 1007 |
|
|
2023
Q3 | $18.8K | Sell |
11,083
-4,917
| -31% | -$8.36K | ﹤0.01% | 927 |
|
|
2023
Q2 | $48K | Buy |
16,000
+3,154
| +25% | +$9.46K | ﹤0.01% | 856 |
|
|
2023
Q1 | $34.4K | Sell |
12,846
-3,327
| -21% | -$8.92K | ﹤0.01% | 929 |
|
|
2022
Q4 | $133K | Buy |
+16,173
| New | +$133K | 0.01% | 892 |
|
|
2022
Q3 | – | Sell |
-15,820
| Closed | -$45K | – | 1485 |
|
|
2022
Q2 | $45K | Buy |
+15,820
| New | +$45K | ﹤0.01% | 1270 |
|